Full Test Bank For
Pharmacology: A Patient-Centered Nursing Process Approach 11th Edition
By Linda E. Mccuistion Kathleen Vuljoin Dimaggio, Mary B. Winton, Jennifer J.
Yeager
,Table Of Contents
Chapter 01: The Nursing Process And Patient-Centered Care .................................................................. 4
Chapter 02: Drug Development And Ethical Considerations .................................................................. 12
Chapter 04: Pharmacogenetics ............................................................................................................... 23
Chapter 03: Pharmacokinetics And Pharmacodynamics ........................................................................ 27
Chapter 05: Complementary And Alternative Therapies ....................................................................... 48
Chapter 06: Pediatric Considerations ..................................................................................................... 56
Chapter 07: Geriatric Considerations ..................................................................................................... 65
Chapter 08: Drugs In Substance Use Disorder ........................................................................................ 73
Chapter 09: Safety And Quality .............................................................................................................. 81
Chapter 10: Drug Administration............................................................................................................ 89
Chapter 11: Drug Calculations ................................................................................................................ 97
Chapter 12: Fluid Volume And Electrolytes .......................................................................................... 103
Chapter 13: Vitamin And Mineral Replacement ................................................................................... 116
Chapter 14: Nutritional Support ........................................................................................................... 126
Chapter 15: Adrenergic Agonists And Antagonists ............................................................................... 137
Chapter 16: Cholinergic Agonists And Antagonists .............................................................................. 145
Chapter 17: Stimulants ......................................................................................................................... 154
Chapter 18: Depressants ...................................................................................................................... 160
Chapter 19: Antiseizure Drugs .............................................................................................................. 169
Chapter 20: Drugs For Parkinsonism And Alzheimer Disease .............................................................. 180
Chapter 21: Drugs For Neuromuscular Disorders And Muscle Spasms ................................................ 189
Chapter 22: Antipsychotics And Anxiolytics ......................................................................................... 197
Chapter 23: Antidepressants And Mood Stabilizers ............................................................................. 208
Chapter 24: Antiinflammatories ........................................................................................................... 218
Chapter 25: Analgesics.......................................................................................................................... 228
Chapter 26: Penicillins, Other Beta-Lactams, And Cephalosporins ...................................................... 237
Chapter 27: Macrolides, Oxazolidinones, Lincosamides, Glycopeptides, Ketolides, And Lipopeptides
.............................................................................................................................................................. 245
Chapter 28: Tetracyclines, Glycylcyclines, Aminoglycosides, And Fluoroquinolones ........................... 250
Chapter 29: Sulfonamides And Nitroimidazoles Antibiotics ................................................................. 256
Chapter 30: Antituberculars, Antifungals, And Antivirals ..................................................................... 263
,Chapter 31: Antimalarials, Anthelmintics, And Peptides ...................................................................... 275
Chapter 32: HIV- And AIDS-Related Drugs ............................................................................................ 279
Chapter 33: Transplant Drugs ............................................................................................................... 285
Chapter 34: Vaccines ............................................................................................................................ 289
Chapter 35: Anticancer Drugs ............................................................................................................... 295
Chapter 36: Targeted Therapies To Treat Cancer .................................................................................. 301
Chapter 37: Biologic Response Modifiers ............................................................................................. 307
Chapter 38: Upper Respiratory Disorders............................................................................................. 314
Chapter 39: Lower Respiratory Disorders ............................................................................................. 321
Chapter 40: Cardiac Glycosides, Antianginals, And Antidysrhythmics ................................................. 333
Chapter 41: Diuretics ............................................................................................................................ 346
Chapter 42: Antihypertensives ............................................................................................................. 353
Chapter 43: Anticoagulants, Antiplatelets, And Thrombolytics............................................................ 363
Chapter 44: Antihyperlipidemics And Drugs To Improve Peripheral Blood Flow ................................. 375
Chapter 45: Gastrointestinal Tract Disorders........................................................................................ 383
Chapter 46: Antiulcer Drugs ................................................................................................................. 395
Chapter 47: Eye And Ear Disorders ....................................................................................................... 406
Chapter 48: Dermatologic Disorders .................................................................................................... 413
Chapter 49: Pituitary, Thyroid, Parathyroid, And Adrenal Disorders .................................................... 421
Chapter 50: Antidiabetics ..................................................................................................................... 434
Chapter 51: Urinary Disorders .............................................................................................................. 445
Chapter 52: Pregnancy And Preterm Labor .......................................................................................... 454
Chapter 53: Labor, Delivery, And Postpartum ...................................................................................... 465
Chapter 54: Neonatal And Newborn .................................................................................................... 473
Chapter 55: Women’s Reproductive Health ......................................................................................... 477
Chapter 56: Men’s Health And Reproductive Disorders ....................................................................... 488
Chapter 57: Sexually Transmitted Infections ........................................................................................ 495
Chapter 58: Adult And Pediatric Emergency Drugs .............................................................................. 500
,Test Bank Pharmacology A Patient-Centered Nursing Process Approach, 11th Edition By Linda E.
Mccuistion Chapter 1-58
Chapter 01: The Nursing Process And Patient-Centered Care
Mccuistion: Pharmacology: A Patient-Centered Nursing Process Approach, 11th Edition
MULTIPLE CHOICE
1. The Nursing Process Is A Five-Step Decision-Making Approach That Includes All Of The
Following Would Be Considered Subjective Data, EXCEPT:
A. Patient-Reported Health History
B. Patient-Reported Signs And Symptoms Of Their Illness
C. Financial Barriers Reported By The Patient’s Caregiver
D. Vital Signs Obtained From The Medical Record
ANS:D
Subjective Data Is Based On What Patients Or Family Members Communicate To The Nurse.
Patient- Reported Health History, Signs And Symptoms, And Caregiver Reported Financial
Barriers Would Be Considered Subjective Data. Vital Signs Obtained From The Medical Record
Would Be Considered Objective Data.
DIF: Cognitive Level: Understanding (Comprehension) TOP: Nursing Process: Planning MSC:
NCLEX: Management Of Client Care
2. The Nurse Is Using Data Collected To Define A Set Of Interventions To Achieve The Most
Desirable Outcomes. Which Of The Following Steps Is The Nurse Applying?
A. Recognizing Cues (Assessment)
B. Analyze Cues & Prioritize Hypothesis (Analysis)
C. Generate Solutions (Planning)
D. Take Action (Nursing Interventions)
ANS:C
When Generating Solutions (Planning), The Nurse Identifies Expected Outcomes And Uses The
Patient’s Problem(S) To Define A Set Of Interventions To Achieve The Most Desirable Outcomes.
Recognizing Cues (Assessment) Involves The Gathering Of Cues (Information) From The Patient
,About Their Health And Lifestyle Practices, Which Are Important Facts That Aid The Nurse In
Making Clinical Care Decisions. Prioritizing Hypothesis Is Used To Organize And Rank The Patient
Problem(S) Identified. Finally, Taking Action Involves Implementation Of Nursing Interventions
To Accomplish The Expected Outcomes.
DIF: Cognitive Level: Understanding (Comprehension) TOP: Nursing Process: Nursing
Intervention
MSC: NCLEX: Management Of Client Care
3. A 5-Year-Old Child With Type 1 Diabetes Mellitus Has Had Repeated Hospitalizations For
Episodes Of Hyperglycemia. The Parents Tell The Nurse That They Can’t Keep Track Of
Everything That Has To Be Done To Care For Their Child. The Nurse Reviews Medications, Diet,
And Symptom Management With The Parents And Draws Up A Daily Checklist For The Family To
Use. These Activities Are Completed In Which Step Of The Nursing Process?
A. Recognizing Cues (Assessment)
B. Analyze Cues & Prioritize Hypothesis (Analysis)
C. Generate Solutions (Planning)
D. Take Action (Nursing Interventions)
ANS:D
Taking Action Through Nursing Interventions Is Where The Nurse Provides Patient Health
Teaching, Drug Administration, Patient Care, And Other Interventions Necessary To Assist The
Patient In Accomplishing Expected Outcomes.
DIF: Cognitive Level: Understanding (Comprehension) TOP: Nursing Process: Nursing
Intervention
MSC: NCLEX: Management Of Client Care
4. The Nurse Is Preparing To Administer A Medication And Reviews The Patient’s Chart For
Drug Allergies, Serum Creatinine, And Blood Urea Nitrogen (BUN) Levels. The Nurse’s Actions
Are Reflective Of Which Of The Following?
A. Recognizing Cues (Assessment)
B. Analyze Cues & Prioritize Hypothesis (Analysis)
, C. Take Action (Nursing Interventions)
D. Generate Solutions (Planning)
ANS:A
Recognizing Cues (Assessment) Involves Gathering Subjective And Objective Information About
The Patient And The Medication. Laboratory Values From The Patient’s Chart Would Be
Considered Collection Of Objective Data.
DIF: Cognitive Level: Understanding (Comprehension)
TOP: Nursing Process: Assessment MSC: NCLEX: Management Of Client Care
5. Which Of The Following Would Be Correctly Categorized As Objective Data?
A. A List Of Herbal Supplements Regularly Used Provided By The Patient.
B. Lab Values Associated With The Drugs The Patient Is Taking.
C. The Ages And Relationship Of All Household Members To The Patient.
D. Usual Dietary Patterns And Food Intake.
ANS:B
Objective Data Are Measured And Detected By Another Person And Would Include Lab Values.
The Other Examples Are Subjective Data.
DIF: Cognitive Level: Understanding (Comprehension)
TOP: Nursing Process: Assessment MSC: NCLEX: Management Of Client Care
6. The Nurse Reviews A Patient’s Database And Learns That The Patient Lives Alone, Is
Forgetful, And Does Not Have An Established Routine. The Patient Will Be Sent Home With
Three New Medications To Be Taken At Different Times Of The Day. The Nurse Develops A Daily
Medication Chart And Enlists A Family Member To Put The Patient’s Pills In A Pill Organizer. This
Is An Example Of Which Element Of The Nursing Process?
A. Recognizing Cues (Assessment)
B. Analyze Cues & Prioritize Hypothesis (Analysis)
C. Take Action (Nursing Interventions)
Pharmacology: A Patient-Centered Nursing Process Approach 11th Edition
By Linda E. Mccuistion Kathleen Vuljoin Dimaggio, Mary B. Winton, Jennifer J.
Yeager
,Table Of Contents
Chapter 01: The Nursing Process And Patient-Centered Care .................................................................. 4
Chapter 02: Drug Development And Ethical Considerations .................................................................. 12
Chapter 04: Pharmacogenetics ............................................................................................................... 23
Chapter 03: Pharmacokinetics And Pharmacodynamics ........................................................................ 27
Chapter 05: Complementary And Alternative Therapies ....................................................................... 48
Chapter 06: Pediatric Considerations ..................................................................................................... 56
Chapter 07: Geriatric Considerations ..................................................................................................... 65
Chapter 08: Drugs In Substance Use Disorder ........................................................................................ 73
Chapter 09: Safety And Quality .............................................................................................................. 81
Chapter 10: Drug Administration............................................................................................................ 89
Chapter 11: Drug Calculations ................................................................................................................ 97
Chapter 12: Fluid Volume And Electrolytes .......................................................................................... 103
Chapter 13: Vitamin And Mineral Replacement ................................................................................... 116
Chapter 14: Nutritional Support ........................................................................................................... 126
Chapter 15: Adrenergic Agonists And Antagonists ............................................................................... 137
Chapter 16: Cholinergic Agonists And Antagonists .............................................................................. 145
Chapter 17: Stimulants ......................................................................................................................... 154
Chapter 18: Depressants ...................................................................................................................... 160
Chapter 19: Antiseizure Drugs .............................................................................................................. 169
Chapter 20: Drugs For Parkinsonism And Alzheimer Disease .............................................................. 180
Chapter 21: Drugs For Neuromuscular Disorders And Muscle Spasms ................................................ 189
Chapter 22: Antipsychotics And Anxiolytics ......................................................................................... 197
Chapter 23: Antidepressants And Mood Stabilizers ............................................................................. 208
Chapter 24: Antiinflammatories ........................................................................................................... 218
Chapter 25: Analgesics.......................................................................................................................... 228
Chapter 26: Penicillins, Other Beta-Lactams, And Cephalosporins ...................................................... 237
Chapter 27: Macrolides, Oxazolidinones, Lincosamides, Glycopeptides, Ketolides, And Lipopeptides
.............................................................................................................................................................. 245
Chapter 28: Tetracyclines, Glycylcyclines, Aminoglycosides, And Fluoroquinolones ........................... 250
Chapter 29: Sulfonamides And Nitroimidazoles Antibiotics ................................................................. 256
Chapter 30: Antituberculars, Antifungals, And Antivirals ..................................................................... 263
,Chapter 31: Antimalarials, Anthelmintics, And Peptides ...................................................................... 275
Chapter 32: HIV- And AIDS-Related Drugs ............................................................................................ 279
Chapter 33: Transplant Drugs ............................................................................................................... 285
Chapter 34: Vaccines ............................................................................................................................ 289
Chapter 35: Anticancer Drugs ............................................................................................................... 295
Chapter 36: Targeted Therapies To Treat Cancer .................................................................................. 301
Chapter 37: Biologic Response Modifiers ............................................................................................. 307
Chapter 38: Upper Respiratory Disorders............................................................................................. 314
Chapter 39: Lower Respiratory Disorders ............................................................................................. 321
Chapter 40: Cardiac Glycosides, Antianginals, And Antidysrhythmics ................................................. 333
Chapter 41: Diuretics ............................................................................................................................ 346
Chapter 42: Antihypertensives ............................................................................................................. 353
Chapter 43: Anticoagulants, Antiplatelets, And Thrombolytics............................................................ 363
Chapter 44: Antihyperlipidemics And Drugs To Improve Peripheral Blood Flow ................................. 375
Chapter 45: Gastrointestinal Tract Disorders........................................................................................ 383
Chapter 46: Antiulcer Drugs ................................................................................................................. 395
Chapter 47: Eye And Ear Disorders ....................................................................................................... 406
Chapter 48: Dermatologic Disorders .................................................................................................... 413
Chapter 49: Pituitary, Thyroid, Parathyroid, And Adrenal Disorders .................................................... 421
Chapter 50: Antidiabetics ..................................................................................................................... 434
Chapter 51: Urinary Disorders .............................................................................................................. 445
Chapter 52: Pregnancy And Preterm Labor .......................................................................................... 454
Chapter 53: Labor, Delivery, And Postpartum ...................................................................................... 465
Chapter 54: Neonatal And Newborn .................................................................................................... 473
Chapter 55: Women’s Reproductive Health ......................................................................................... 477
Chapter 56: Men’s Health And Reproductive Disorders ....................................................................... 488
Chapter 57: Sexually Transmitted Infections ........................................................................................ 495
Chapter 58: Adult And Pediatric Emergency Drugs .............................................................................. 500
,Test Bank Pharmacology A Patient-Centered Nursing Process Approach, 11th Edition By Linda E.
Mccuistion Chapter 1-58
Chapter 01: The Nursing Process And Patient-Centered Care
Mccuistion: Pharmacology: A Patient-Centered Nursing Process Approach, 11th Edition
MULTIPLE CHOICE
1. The Nursing Process Is A Five-Step Decision-Making Approach That Includes All Of The
Following Would Be Considered Subjective Data, EXCEPT:
A. Patient-Reported Health History
B. Patient-Reported Signs And Symptoms Of Their Illness
C. Financial Barriers Reported By The Patient’s Caregiver
D. Vital Signs Obtained From The Medical Record
ANS:D
Subjective Data Is Based On What Patients Or Family Members Communicate To The Nurse.
Patient- Reported Health History, Signs And Symptoms, And Caregiver Reported Financial
Barriers Would Be Considered Subjective Data. Vital Signs Obtained From The Medical Record
Would Be Considered Objective Data.
DIF: Cognitive Level: Understanding (Comprehension) TOP: Nursing Process: Planning MSC:
NCLEX: Management Of Client Care
2. The Nurse Is Using Data Collected To Define A Set Of Interventions To Achieve The Most
Desirable Outcomes. Which Of The Following Steps Is The Nurse Applying?
A. Recognizing Cues (Assessment)
B. Analyze Cues & Prioritize Hypothesis (Analysis)
C. Generate Solutions (Planning)
D. Take Action (Nursing Interventions)
ANS:C
When Generating Solutions (Planning), The Nurse Identifies Expected Outcomes And Uses The
Patient’s Problem(S) To Define A Set Of Interventions To Achieve The Most Desirable Outcomes.
Recognizing Cues (Assessment) Involves The Gathering Of Cues (Information) From The Patient
,About Their Health And Lifestyle Practices, Which Are Important Facts That Aid The Nurse In
Making Clinical Care Decisions. Prioritizing Hypothesis Is Used To Organize And Rank The Patient
Problem(S) Identified. Finally, Taking Action Involves Implementation Of Nursing Interventions
To Accomplish The Expected Outcomes.
DIF: Cognitive Level: Understanding (Comprehension) TOP: Nursing Process: Nursing
Intervention
MSC: NCLEX: Management Of Client Care
3. A 5-Year-Old Child With Type 1 Diabetes Mellitus Has Had Repeated Hospitalizations For
Episodes Of Hyperglycemia. The Parents Tell The Nurse That They Can’t Keep Track Of
Everything That Has To Be Done To Care For Their Child. The Nurse Reviews Medications, Diet,
And Symptom Management With The Parents And Draws Up A Daily Checklist For The Family To
Use. These Activities Are Completed In Which Step Of The Nursing Process?
A. Recognizing Cues (Assessment)
B. Analyze Cues & Prioritize Hypothesis (Analysis)
C. Generate Solutions (Planning)
D. Take Action (Nursing Interventions)
ANS:D
Taking Action Through Nursing Interventions Is Where The Nurse Provides Patient Health
Teaching, Drug Administration, Patient Care, And Other Interventions Necessary To Assist The
Patient In Accomplishing Expected Outcomes.
DIF: Cognitive Level: Understanding (Comprehension) TOP: Nursing Process: Nursing
Intervention
MSC: NCLEX: Management Of Client Care
4. The Nurse Is Preparing To Administer A Medication And Reviews The Patient’s Chart For
Drug Allergies, Serum Creatinine, And Blood Urea Nitrogen (BUN) Levels. The Nurse’s Actions
Are Reflective Of Which Of The Following?
A. Recognizing Cues (Assessment)
B. Analyze Cues & Prioritize Hypothesis (Analysis)
, C. Take Action (Nursing Interventions)
D. Generate Solutions (Planning)
ANS:A
Recognizing Cues (Assessment) Involves Gathering Subjective And Objective Information About
The Patient And The Medication. Laboratory Values From The Patient’s Chart Would Be
Considered Collection Of Objective Data.
DIF: Cognitive Level: Understanding (Comprehension)
TOP: Nursing Process: Assessment MSC: NCLEX: Management Of Client Care
5. Which Of The Following Would Be Correctly Categorized As Objective Data?
A. A List Of Herbal Supplements Regularly Used Provided By The Patient.
B. Lab Values Associated With The Drugs The Patient Is Taking.
C. The Ages And Relationship Of All Household Members To The Patient.
D. Usual Dietary Patterns And Food Intake.
ANS:B
Objective Data Are Measured And Detected By Another Person And Would Include Lab Values.
The Other Examples Are Subjective Data.
DIF: Cognitive Level: Understanding (Comprehension)
TOP: Nursing Process: Assessment MSC: NCLEX: Management Of Client Care
6. The Nurse Reviews A Patient’s Database And Learns That The Patient Lives Alone, Is
Forgetful, And Does Not Have An Established Routine. The Patient Will Be Sent Home With
Three New Medications To Be Taken At Different Times Of The Day. The Nurse Develops A Daily
Medication Chart And Enlists A Family Member To Put The Patient’s Pills In A Pill Organizer. This
Is An Example Of Which Element Of The Nursing Process?
A. Recognizing Cues (Assessment)
B. Analyze Cues & Prioritize Hypothesis (Analysis)
C. Take Action (Nursing Interventions)
